Condition
AIHA - Cold Autoimmune Hemolytic Anemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 AIHA - Cold Autoimmune Hemolytic Anemia clinical trials that are recruiting, at sites in 3 countries (most in Australia (1), United States (1), China (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
OM336 for autoimmune hemolytic anemia and immune thrombocytopenia
This phase 1 trial will test whether subcutaneously given OM336 is safe and tolerable in adults with relapsed or refractory autoimmune hemolytic anemia or immune thrombocytopenia.
-
National longitudinal cohort of autoimmune hemolytic anemia in China
This project will follow people with warm, cold, or mixed autoimmune hemolytic anemia treated at a major Tianjin hematology center to see what treatments they receive and how well they do over time.
Related topics
Quick answers
How many AIHA - Cold Autoimmune Hemolytic Anemia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (1 trial), United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.